MP-3180

MediBeacon · Phase 1 active Small molecule

At a glance

Generic name	MP-3180
Sponsor	MediBeacon
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers (PHASE1)
Pharmacokinetics of MP-3180 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MP-3180 CI brief — competitive landscape report
MP-3180 updates RSS · CI watch RSS
MediBeacon portfolio CI